RNA editing biotech Airna adds $155M in funding
Airna will use the Series B round to launch a Phase 1/2 trial of its lead program for alpha-1 antitrypsin deficiency, a disease targeted by several other firms.
Pramoedya Ananta Toer: Hundred years of a fearless Indonesian literary icon
The author’s iconic ‘Buru Quartet’ about the independence struggle against the Dutch colonial rule was banned in Indonesia ...
World Politics Review on MSN6d
The West Will Need the Global South to Build the Post-American Order
As the U.S. abandons the liberal international order, the rest of the West is trying to regroup. But it would be a mistake ...